Medical Writing & Documentation

Governance, Version Control and Traceability in Lay Summaries & Plain-Language Results

Posted on By digi

Governance, Version Control and Traceability in Lay Summaries & Plain-Language Results Governance, Version Control and Traceability in Lay Summaries & Plain-Language Results In the realm of clinical trials, the preparation of lay summaries and plain-language results has gained significant importance. This is particularly true given the regulatory frameworks outlined by agencies such as the FDA,…

Read More “Governance, Version Control and Traceability in Lay Summaries & Plain-Language Results” »

Lay Summaries & Plain-Language Results

Training and Competency Building for Teams Authoring Lay Summaries & Plain-Language Results

Posted on By digi

Training and Competency Building for Teams Authoring Lay Summaries & Plain-Language Results Training and Competency Building for Teams Authoring Lay Summaries & Plain-Language Results Creating lay summaries and plain-language results is a crucial component of medical writing within clinical trials. These documents serve to inform non-specialist audiences about clinical trial results, enhancing public understanding and…

Read More “Training and Competency Building for Teams Authoring Lay Summaries & Plain-Language Results” »

Lay Summaries & Plain-Language Results

Cross-Functional Collaboration Models to Deliver High-Quality Lay Summaries & Plain-Language Results

Posted on By digi

Cross-Functional Collaboration Models to Deliver High-Quality Lay Summaries & Plain-Language Results The development of lay summaries and plain-language results is an essential facet of clinical research. These documents serve to communicate complex biomedical information in a manner that is accessible to non-specialist audiences, including patients and the general public. This article will delineate step-by-step models…

Read More “Cross-Functional Collaboration Models to Deliver High-Quality Lay Summaries & Plain-Language Results” »

Lay Summaries & Plain-Language Results

Aligning Safety Narratives & Case Reports With Protocol, SAP and Risk Management Strategies

Posted on By digi

Aligning Safety Narratives & Case Reports With Protocol, SAP and Risk Management Strategies Aligning Safety Narratives & Case Reports With Protocol, SAP and Risk Management Strategies In today’s complex landscape of clinical research, ensuring the integrity and accuracy of safety narratives and case reports is critical for regulatory compliance and the successful advancement of therapeutic…

Read More “Aligning Safety Narratives & Case Reports With Protocol, SAP and Risk Management Strategies” »

Safety Narratives & Case Reports

Common Deficiencies in Safety Narratives & Case Reports—and How to Avoid Regulatory Findings

Posted on By digi

Common Deficiencies in Safety Narratives & Case Reports—and How to Avoid Regulatory Findings Common Deficiencies in Safety Narratives & Case Reports—and How to Avoid Regulatory Findings In the realm of clinical research, safety narratives and case reports serve as crucial documentation that summarizes adverse events and clinical findings associated with drug usage. These documents are…

Read More “Common Deficiencies in Safety Narratives & Case Reports—and How to Avoid Regulatory Findings” »

Safety Narratives & Case Reports

Safety Narratives & Case Reports in Practice: Step-by-Step Guide for Medical Writers

Posted on By digi

Safety Narratives & Case Reports in Practice: Step-by-Step Guide for Medical Writers In the realm of clinical trial management services, ensuring accurate and comprehensive safety narratives and case reports are essential for compliance and efficacy. This step-by-step guide is tailored for medical writers, clinical operations, regulatory affairs, and medical affairs professionals who seek to enhance…

Read More “Safety Narratives & Case Reports in Practice: Step-by-Step Guide for Medical Writers” »

Safety Narratives & Case Reports

How to Develop Safety Narratives & Case Reports That Meet FDA, EMA and MHRA Expectations

Posted on By digi

How to Develop Safety Narratives & Case Reports That Meet FDA, EMA and MHRA Expectations In the context of clinical trials, particularly those governed by FDA, EMA, and MHRA regulations, the proper development of safety narratives and case reports is essential. These documents not only communicate vital safety information but also guide decision-making processes in…

Read More “How to Develop Safety Narratives & Case Reports That Meet FDA, EMA and MHRA Expectations” »

Safety Narratives & Case Reports

Safety Narratives & Case Reports: Inspection-Ready Standards for Global Clinical Programs

Posted on By digi

Safety Narratives & Case Reports: Inspection-Ready Standards for Global Clinical Programs Introduction to Safety Narratives in Clinical Trials In the realm of clinical trials, safety narratives are vital components of the clinical study documentation process. These narratives provide a comprehensive summary of adverse events (AEs), serious adverse events (SAEs), and other safety data collected throughout…

Read More “Safety Narratives & Case Reports: Inspection-Ready Standards for Global Clinical Programs” »

Safety Narratives & Case Reports

Integrating Safety Narratives & Case Reports With CTD/eCTD and Publishing Workflows

Posted on By digi

Integrating Safety Narratives & Case Reports With CTD/eCTD and Publishing Workflows Clinical trials, particularly those concerning ulcerative colitis clinical trials, demand meticulous documentation practices to ensure adherence to regulatory standards and to optimize data dissemination. This article serves as a comprehensive guide for professionals in clinical operations, regulatory affairs, and medical affairs, focusing on effectively…

Read More “Integrating Safety Narratives & Case Reports With CTD/eCTD and Publishing Workflows” »

Safety Narratives & Case Reports

Case Studies: Safety Narratives & Case Reports That Supported Successful Submissions

Posted on By digi

Case Studies: Safety Narratives & Case Reports That Supported Successful Submissions Case Studies: Safety Narratives & Case Reports That Supported Successful Submissions In clinical research, particularly in Crohn’s disease clinical trials and ulcerative colitis clinical trials, the creation of safety narratives and case reports plays a crucial role in regulatory submissions. This article serves as…

Read More “Case Studies: Safety Narratives & Case Reports That Supported Successful Submissions” »

Safety Narratives & Case Reports